Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.
Saved in:
| Title: | Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML. |
|---|---|
| Authors: | Joisten CS; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Mellinghoff SC; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Seidel D; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Müller C; TDM Laboratory, Center for Laboratory Diagnostics, University Hospital of Cologne, Cologne, Germany., Müller-Ohrem C; TDM Laboratory, Center for Laboratory Diagnostics, University Hospital of Cologne, Cologne, Germany., Kreuzer K-A; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Frenzel LP; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Simon F; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Koehler P; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; Department I of Internal Medicine, Division of Clinical Immunology, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Cornely OA; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Clinical Trials Center Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Stemler J; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2026 Jun 03; Vol. 70 (6), pp. e0195125. Date of Electronic Publication: 2026 May 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42118097 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Joisten+CS%22">Joisten CS</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Mellinghoff+SC%22">Mellinghoff SC</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Seidel+D%22">Seidel D</searchLink>; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+C%22">Müller C</searchLink>; TDM Laboratory, Center for Laboratory Diagnostics, University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Ohrem+C%22">Müller-Ohrem C</searchLink>; TDM Laboratory, Center for Laboratory Diagnostics, University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Kreuzer+K-A%22">Kreuzer K-A</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Frenzel+LP%22">Frenzel LP</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Simon+F%22">Simon F</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Koehler+P%22">Koehler P</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; Department I of Internal Medicine, Division of Clinical Immunology, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Cornely+OA%22">Cornely OA</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Clinical Trials Center Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Stemler+J%22">Stemler J</searchLink>; Department I of Internal Medicine, Center for Integrated Oncology (CIO), Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, Institute of Translational Research, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2026 Jun 03; Vol. 70 (6), pp. e0195125. <i>Date of Electronic Publication: </i>2026 May 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42118097 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1128/aac.01951-25 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0195125 Titles: – TitleFull: Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Joisten CS – PersonEntity: Name: NameFull: Mellinghoff SC – PersonEntity: Name: NameFull: Seidel D – PersonEntity: Name: NameFull: Müller C – PersonEntity: Name: NameFull: Müller-Ohrem C – PersonEntity: Name: NameFull: Kreuzer K-A – PersonEntity: Name: NameFull: Frenzel LP – PersonEntity: Name: NameFull: Simon F – PersonEntity: Name: NameFull: Hallek M – PersonEntity: Name: NameFull: Koehler P – PersonEntity: Name: NameFull: Cornely OA – PersonEntity: Name: NameFull: Stemler J IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2026 Jun 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1098-6596 Numbering: – Type: volume Value: 70 – Type: issue Value: 6 Titles: – TitleFull: Antimicrobial agents and chemotherapy Type: main |
| ResultId | 1 |